Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
20 11 2020
Historique:
entrez: 21 11 2020
pubmed: 22 11 2020
medline: 15 12 2020
Statut: epublish

Résumé

Metagenomic next-generation sequencing (mNGS) offers an agnostic approach for emerging pathogen detection directly from clinical specimens. In contrast to targeted methods, mNGS also provides valuable information on the composition of the microbiome and might uncover coinfections that may associate with disease progression and impact prognosis. To evaluate the use of mNGS for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and/or other infecting pathogens, we applied direct Oxford Nanopore long-read third-generation metatranscriptomic and metagenomic sequencing. Nasopharyngeal (NP) swab specimens from 50 patients under investigation for CoV disease 2019 (COVID-19) were sequenced, and the data were analyzed by the CosmosID bioinformatics platform. Further, we characterized coinfections and the microbiome associated with a four-point severity index. SARS-CoV-2 was identified in 77.5% (31/40) of samples positive by RT-PCR, correlating with lower cycle threshold (Ct) values and fewer days from symptom onset. At the time of sampling, possible bacterial or viral coinfections were detected in 12.5% of SARS-CoV-2-positive specimens. A decrease in microbial diversity was observed among COVID-19-confirmed patients (Shannon diversity index,

Identifiants

pubmed: 33219095
pii: mBio.01969-20
doi: 10.1128/mBio.01969-20
pmc: PMC7686804
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 Mostafa et al.

Références

Pneumonia (Nathan). 2015 Dec 1;6:26-43
pubmed: 31641576
JCI Insight. 2021 Mar 22;6(6):
pubmed: 33749660
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Bioinformatics. 2016 Jan 15;32(2):292-4
pubmed: 26428292
Clin Infect Dis. 2020 Jul 28;71(15):713-720
pubmed: 32129843
BMC Microbiol. 2016 Nov 16;16(1):275
pubmed: 27852235
J Infect. 2020 Aug;81(2):266-275
pubmed: 32473235
Appl Environ Microbiol. 2012 Sep;78(17):6262-70
pubmed: 22752171
Nat Microbiol. 2020 Mar;5(3):443-454
pubmed: 31932713
JAMA. 2020 May 26;323(20):2085-2086
pubmed: 32293646
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):722-7
pubmed: 26733683
Am J Respir Crit Care Med. 2020 Mar 1;201(5):555-563
pubmed: 31973575
Small. 2020 Aug;16(32):e2002169
pubmed: 32578378
Infect Immun. 1994 May;62(5):1710-8
pubmed: 8168932
Front Immunol. 2019 Jul 04;10:1551
pubmed: 31333675
PLoS Pathog. 2014 Nov 20;10(11):e1004437
pubmed: 25412476
Crit Rev Microbiol. 2019 Feb;45(1):103-117
pubmed: 30663924
Science. 2014 Aug 29;345(6200):1048-52
pubmed: 25170151
J Infect Dis. 2003 Mar 1;187(5):785-90
pubmed: 12599052
Clin Infect Dis. 2020 Dec 17;71(10):2736-2743
pubmed: 32361747
J Med Virol. 2020 Sep;92(9):1383-1385
pubmed: 32297981
mBio. 2016 Jan 05;7(1):e01725-15
pubmed: 26733066
BMC Biol. 2019 Nov 7;17(1):87
pubmed: 31699101
Clin Chem. 2020 Jul 1;66(7):966-972
pubmed: 32379863
Am J Respir Crit Care Med. 2018 Mar 1;197(5):621-631
pubmed: 29035085
Emerg Microbes Infect. 2020 Dec;9(1):313-319
pubmed: 32020836
Crit Care Med. 2017 Oct;45(10):1683-1695
pubmed: 28787295
mBio. 2011 Feb 01;2(1):e00245-10
pubmed: 21285435
Genome Med. 2015 Sep 29;7:99
pubmed: 26416663
J Clin Microbiol. 2019 Jan 30;57(2):
pubmed: 30429253
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468
pubmed: 32358954
J Med Virol. 2020 Oct;92(10):1699-1700
pubmed: 32352574
Lancet Respir Med. 2019 May;7(5):417-426
pubmed: 30885620
PLoS One. 2014 May 20;9(5):e97699
pubmed: 24846174
J Med Virol. 2020 Oct;92(10):1799-1801
pubmed: 32320082
J Clin Virol. 2020 Jun;127:104384
pubmed: 32361285
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Am J Respir Crit Care Med. 2008 May 1;177(9):995-1001
pubmed: 18263800
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Virus Res. 2020 Aug;285:198005
pubmed: 32408156

Auteurs

Heba H Mostafa (HH)

Division of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

John A Fissel (JA)

Division of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Brian Fanelli (B)

CosmosID, Inc., Rockville, Maryland, USA.

Yehudit Bergman (Y)

Division of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Victoria Gniazdowski (V)

Division of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Manoj Dadlani (M)

CosmosID, Inc., Rockville, Maryland, USA.

Karen C Carroll (KC)

Division of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Rita R Colwell (RR)

CosmosID, Inc., Rockville, Maryland, USA.
University of Maryland College Park, Institute for Advanced Computer Studies, College Park, Maryland, USA.

Patricia J Simner (PJ)

Division of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA psimner1@jhmi.edu.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH